BrightInsight
United States
- San Jose, CA
- 21/01/2026
- Unknown
- $13,000,000
For life sciences companies pursuing digital transformation, we offer the leading technology to rapidly develop, launch, and scale digital solutions.
Our cloud-based platform is the trusted foundation for companion apps, algorithms, connected combination products, healthcare provider interfaces and other Software as a Medical Device (SaMD).
Our customers partner with BrightInsight to differentiate their therapies and harness unique real-world data to drive measurable value.
With a track record of successful product launches that yield business and clinical ROI for top life sciences companies’ flagship brands in their largest markets, BrightInsight is the proven leader in this space.
- Industry IT Services and IT Consulting
- Website https://brightinsight.com/
- LinkedIn https://www.linkedin.com/company/brightinsight-inc/
Related People
Kal Patel, M.D., MBAFounder
United States -
San Francisco Bay Area
Currently CEO and Co-Founder of BrightInsight
Previously Senior Advisor for Digital Health to The Boston Consulting Group and Chief Commercial Officer for Doctor on Demand driving the transformation from a direct-to-consumer offering to an enterprise service offered through employers, health plans and health systems.
Formerly Head of Amgen Digital Health with responsibility for setting and executing Amgen’s digital health strategy focused on incubating and commercializing portfolio of digital health products and programs that support Amgen’s drugs including next-generation digital marketing, advanced data & analytics, wearable technologies, web-enabled technologies, clinical decision software and connectivity.
Previously Global Marketing Lead for Enbrel, a top 10 biopharmaceutical brand. Led the creation, prioritization, and execution of the short and long term lifecycle plan for leading Amgen product with $4B+ in annual sales.
Prior to Global Marketing, led the corporate strategy function for Amgen. Partnered closely with C-suite management to define and deliver against key strategic priorities and programs.
Prior to Amgen, in sales & marketing leadership with Novartis Pharmaceuticals, leading a team with responsibility to develop and implement strategies to increase revenue and improve profitability of a U.S. sales and marketing division with over 1000 employees and $1B+ in sales. Additionally, direct P&L responsibility for $200M+ in sales and 200+ sales representatives and managers.
7+ years of experience with Boston Consulting Group. Based in the U.S. and Europe with a focus on the healthcare industry. Lead BCG teams at healthcare clients across pharma, medical devices, payers and healthcare services.
Specialties: Business strategy
Corporate development
Operational performance improvement
Organizational design
Sales & marketing effectiveness
Biotechnology
Pharmaceuticals
Medical Devices
Payers
Healthcare services
Infinitopes | $15,400,000 | (Jan 21, 2026)
Statusphere | $18,000,000 | (Jan 21, 2026)
Think Bioscience | $55,000,000 | (Jan 21, 2026)
POINT.LAZ | $3,000,000 | (Jan 21, 2026)
Formulary Financial | $4,600,000 | (Jan 21, 2026)
Ultra Pouches | $11,000,000 | (Jan 21, 2026)
XBuild | $19,000,000 | (Jan 21, 2026)
Dam Secure | $4,000,000 | (Jan 21, 2026)
Fleetzero | $43,000,000 | (Jan 20, 2026)
EXCIVA GmbH | $59,817,135 | (Jan 20, 2026)
Dominion Dynamics | $15,200,000 | (Jan 20, 2026)